-
Esperion Therapeutics (NASDAQ:ESPR) Rating Increased to Buy at StockNews.com
Источник: Buzz FX / 07 ноя 2024 02:32:16 America/New_York
Esperion Therapeutics (NASDAQ:ESPR) Rating Increased to Buy at StockNews.com Written by MarketBeat November 7, 2024 Share Link copied to clipboard. Esperion Therapeutics ( NASDAQ:ESPR - Get Free Report ) was upgraded by research analysts at
Read more...